Radboud University Medical Center Becomes First Hospital in the Netherlands to Win HIMSS Stage 7 Award

HIMSS EuropeHIMSS Analytics Europe, subsidiary of HIMSS Europe, has awarded Radboud university medical center with the Stage 7 Award, making it the first HIMSS Stage 7 hospital in the Netherlands and the third in Europe.

The hospital, which has 953 beds, joins the University Medical Centre Hamburg-Eppendorf in Germany and the Hospital de Dénia-Marina Salud in Spain in the highest stage of the European EMR Adoption Model (EMRAM) developed by HIMSS.

The Netherlands enjoy a high number of Stage 6 awarded hospitals, which consolidates this country as one of the European leaders in ehealth. Beside Radboudumc, as of today, 10 Dutch hospitals and university medical centers have achieved Stage 6. Across Europe there are more than 50 hospitals recognized in the Stage 6 category.

EMRAM has been adapted to meet the needs of European healthcare institutions as a methodology for evaluating the progress and impact of electronic medical record systems in hospitals. Tracking their progress in completing eight stages (0‐7), hospitals can review the implementation and utilization of information technology applications with the aim of reaching Stage 7, which represents a superior electronic patient record environment.

Hospitals that reach Stage 7 support the true sharing and use of patient data to improve process performance, quality of care and patient safety. Uwe Buddrus, senior consultant at HIMSS Analytics Europe, said: "Radboudumc is only the third hospital in Europe to achieve the prestigious HIMSS EMRAM Stage 7 Award and the first within two years during which many European hospitals - more than 1100 in Europe, 62 of which in The Netherlands - participated in the EMRAM evaluation. I am very happy that HIMSS has identified another best practice example in Europe, which I am sure will stimulate many other hospitals on their journey towards improving healthcare delivery by the use of hospital IT solutions."

Buddrus adds: "Radboudumc is also the first fully approved member of the HIMSS Stage 6 & 7 Club, and expected to take a leading role in providing continuous evidence of the benefits of IT. Among the many highlights of Radboudumc's achievements since its last evaluation and recognition as Stage 6, I'd like to emphasize their approach towards medication safety, as well as Clinical Decision Support."

For more information on the stage 7 award visit http://himssanalytics.eu/emram/

About HIMSS Analytics Europe
HIMSS Analytics Europe (HAE) provides health care organisations, governments and industry with extensive data resources and services about the adoption and use of healthcare information technology in Europe. HAE’s offerings include comparative Hospital IT adoption benchmarking, a European‐formulated EMR Adoption Model (EMRAM) scale, and other resources to help hospital directors, IT executives and clinicians compare and measure their progress and how they compare to others. Country level and application specific reports also provide insights into major IT adoption trends and applications.

About Radboud university medical centre
Radboud university medical center founded in 1951, is an institute for patient care, research and education & training, located in Nijmegen in the Netherlands. Our mission is to have a significant impact on healthcare. We aim to be a frontrunner in the development of innovative, sustainable and affordable healthcare. We offer excellent quality, participatory and personalised healthcare, operational excellence and sustainable networks. Our almost 10,000 employees and over 3,000 students do their utmost every day to make a positive contribution to the future of healthcare and medical sciences.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...